Translating decades of hormone receptor research into transformative oncology treatments.

At TR Beta Oncology, our mission is to unlock the therapeutic potential of thyroid hormone receptor beta (TRβ) to transform the treatment of advanced and resistant cancers. By selectively activating TRβ, we aim to restore tumor-suppressive signaling pathways while minimizing toxicity — offering patients smarter, safer, and more durable treatment options.